Manidipine for Hypertension not Controlled by Dual Therapy in Patients with Diabetes Mellitus: A Non-Comparative, Open-Label Study

By Martell-Claros Nieves  

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 427-434

Adis International

Access to resources Recommend Favorite

Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer: An Open-Label, Non-Comparative, Multicentre, Phase III Study

By Lundström Eija A.  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 757-765

Adis International

Access to resources Recommend Favorite

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma

By Reichardt Peter   Oechsle Karin   Pink Daniel   Bokemeyer Carsten   Schneller F.   Issels Rolf   Kanz Lothar   Hartmann Jörg Thomas  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 481-486

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension: A Double-Blind, Placebo-Controlled, Dose-Titration Study

By Guthrie R.  

Clinical Drug Investigation, Vol. 15, Iss. 3, 1998-03 ,pp. : 217-227

Adis International

Access to resources Recommend Favorite

An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma

By Hartmann J.   Oechsle K.   Huober J.   Jakob A.   Azemar M.   Horger M.   Kanz L.   Bokemeyer C.  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 249-253

Springer Publishing Company

Access to resources Recommend Favorite